Literature DB >> 24177804

Intermittent neutropenia as an early feature of mild mevalonate kinase deficiency.

Nima Parvaneh1, Vahid Ziaee, Mohammad-Hassan Moradinejad, Isabelle Touitou.   

Abstract

A 15-month-old boy, born to Iranian consanguineous parents presented with intermittent neutropenia interspersed with episodes of fever and leukocytosis since early infancy. No ELA2 mutations were found and the bone marrow study was normal. At age 4 years he progressed to more typical attacks of periodic attacks of fever, abdominal pain, oral aphthous ulcers, cutaneous rash and leukocytosis. The clinical and laboratory features were compatible with the mild form of mevalonate kinase deficiency, usually named "Hyper-IgD and periodic fever syndrome" (HIDS). Genomic sequencing of the mevalonate kinase (MVK) gene revealed homozygous missense mutation (p.Val377Ile). On demand dexamethasone resulted in a rapid amelioration of febrile episodes. The presentation of intermittent neutropenia has not been reported in HIDS and deserves more attention in large patient cohorts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24177804     DOI: 10.1007/s10875-013-9955-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

Review 1.  Hereditary periodic fever.

Authors:  J P Drenth; J W van der Meer
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

Review 2.  Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes.

Authors:  Anna Simon; Jos W M van der Meer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-24       Impact factor: 3.619

3.  Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Authors:  J W van der Meer; J M Vossen; J Radl; J A van Nieuwkoop; C J Meyer; S Lobatto; R van Furth
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

4.  Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.

Authors:  L Cuisset; J P Drenth; A Simon; M F Vincent; S van der Velde Visser; J W van der Meer; G Grateau; M Delpech
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

Review 5.  Hyper-IgD syndrome or mevalonate kinase deficiency.

Authors:  Monique Stoffels; Anna Simon
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

Review 6.  How to approach neutropenia.

Authors:  Laurence A Boxer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 7.  Cyclic neutropenia.

Authors:  David C Dale; Audrey Anna Bolyard; Andrew Aprikyan
Journal:  Semin Hematol       Date:  2002-04       Impact factor: 3.851

8.  MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.

Authors:  Andrea D'Osualdo; Paolo Picco; Francesco Caroli; Marco Gattorno; Raffaella Giacchino; Patrizia Fortini; Fabrizia Corona; Alberto Tommasini; Giuseppe Salvi; Fernando Specchia; Laura Obici; Antonella Meini; Antonio Ricci; Marco Seri; Roberto Ravazzolo; Alberto Martini; Isabella Ceccherini
Journal:  Eur J Hum Genet       Date:  2005-03       Impact factor: 4.246

9.  A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.

Authors:  Ayman Samkari; Arturo Borzutzky; Elisa Fermo; Diana O Treaba; Fatma Dedeoglu; Rachel A Altura
Journal:  Pediatrics       Date:  2010-03-01       Impact factor: 7.124

10.  Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.

Authors:  Jeroen C H van der Hilst; Evelien J Bodar; Karyl S Barron; Joost Frenkel; Joost P H Drenth; Jos W M van der Meer; Anna Simon
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

View more
  4 in total

Review 1.  Inborn errors of metabolism underlying primary immunodeficiencies.

Authors:  Nima Parvaneh; Pierre Quartier; Parastoo Rostami; Jean-Laurent Casanova; Pascale de Lonlay
Journal:  J Clin Immunol       Date:  2014-08-01       Impact factor: 8.317

2.  Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis.

Authors:  Hassan Abolhassani; Fatemeh Kiaee; Marzieh Tavakol; Zahra Chavoshzadeh; Seyed Alireza Mahdaviani; Tooba Momen; Reza Yazdani; Gholamreza Azizi; Sima Habibi; Mohammad Gharagozlou; Masoud Movahedi; Amir Ali Hamidieh; Nasrin Behniafard; Mohammamd Nabavi; Mohammad Hassan Bemanian; Saba Arshi; Rasol Molatefi; Roya Sherkat; Afshin Shirkani; Reza Amin; Soheila Aleyasin; Reza Faridhosseini; Farahzad Jabbari-Azad; Iraj Mohammadzadeh; Javad Ghaffari; Alireza Shafiei; Arash Kalantari; Mahboubeh Mansouri; Mehrnaz Mesdaghi; Delara Babaie; Hamid Ahanchian; Maryam Khoshkhui; Habib Soheili; Mohammad Hossein Eslamian; Taher Cheraghi; Abbas Dabbaghzadeh; Mahmoud Tavassoli; Rasoul Nasiri Kalmarzi; Seyed Hamidreza Mortazavi; Sara Kashef; Hossein Esmaeilzadeh; Javad Tafaroji; Abbas Khalili; Fariborz Zandieh; Mahnaz Sadeghi-Shabestari; Sepideh Darougar; Fatemeh Behmanesh; Hedayat Akbari; Mohammadreza Zandkarimi; Farhad Abolnezhadian; Abbas Fayezi; Mojgan Moghtaderi; Akefeh Ahmadiafshar; Behzad Shakerian; Vahid Sajedi; Behrang Taghvaei; Mojgan Safari; Marzieh Heidarzadeh; Babak Ghalebaghi; Seyed Mohammad Fathi; Behzad Darabi; Saeed Bazregari; Nasrin Bazargan; Morteza Fallahpour; Alireza Khayatzadeh; Naser Javahertrash; Bahram Bashardoust; Mohammadali Zamani; Azam Mohsenzadeh; Sarehsadat Ebrahimi; Samin Sharafian; Ahmad Vosughimotlagh; Mitra Tafakoridelbari; Maziar Rahimi; Parisa Ashournia; Anahita Razaghian; Arezou Rezaei; Setareh Mamishi; Nima Parvaneh; Nima Rezaei; Lennart Hammarström; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-10-09       Impact factor: 8.317

Review 3.  Hyper-IgD syndrome/mevalonate kinase deficiency: what is new?

Authors:  C M Mulders-Manders; A Simon
Journal:  Semin Immunopathol       Date:  2015-05-20       Impact factor: 9.623

4.  Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.

Authors:  Zahra Ahmadinejad; Sedigeh Mansouri; Vahid Ziaee; Yahya Aghighi; Mohammad-Hassan Moradinejad; Fatemeh Fereshteh-Mehregan
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.